Direct-to-consumer advertising under fire

Humphreys, Gary
August 2009
Bulletin of the World Health Organization;Aug2009, Vol. 87 Issue 8, p576
Academic Journal
The article discusses direct-to-consumer advertising by pharmaceutical companies and U.S. government pressure being applied to curtail this marketing technique. New Zealand's Dr. Dee Mangin says that such advertising is aired to drive personal choice rather than educate it. The article notes the example of Dr. Robert Jarvik and his role in television commercial for Pfizer's cholesterol drug Lipitor. It debunks Jarvik's credentials as a medical practitioner and as the inventor of the artificial heart.


Related Articles

  • Direct to consumer advertising of prescription drugs. Mintzes, Barbara // BMJ: British Medical Journal (International Edition);9/6/2008, Vol. 337 Issue 7669, p526 

    The author reflects on direct-to-consumer advertising of prescription drugs. She suggests that even forms of direct-to-consumer drug advertising which occurs across borders can cause harm. She argues that research and debates have suggested that the advertising causes harm to women and has...

  • Pfizer cans Lipitor ads, vowing 'larity'. Arnold, Matthew // Medical Marketing & Media;Apr2008, Vol. 43 Issue 4, p28 

    The article reports on the issues behind the implementation of the Lipitor direct-to-consumer advertising (DTC ad) by Pfizer Inc. in the U.S. It notes that the issues had erupted due to the inclusion of Doctor Robert Jarvik as the centerpiece in the DTC ad, and likewise mentions that it became a...

  • DDR on DTC. Dick-Rath, Deborah // Medical Marketing & Media;Jun2011, Vol. 46 Issue 6, p24 

    The article offers the author's insights on the direct-to-consumer (DTC) advertising of GlaxoSmithKline's Lovaza drug.

  • Point: Pharmaceutical Companies Should Not Be Allowed to Advertise. Walter, Andrew // Points of View: Pharmaceuticals Advertising;3/1/2016, p2 

    The article presents an argument against direct-to-consumer (DTC) advertisement of prescription drugs. The author argues that such ads are dangerous, misleading, and unethical. The effect of pharmaceutical advertising campaigns on prescription drug use, marketing prescription drugs to...

  • Jarvik Dropped from Pfizer Advertising, but Scrutiny Remains. P., Shankar // njbiz;3/3/2008, Vol. 21 Issue 10, p2 

    The article reports that Pfizer Inc. could face continued investigations into its advertising practices even though it stopped airing in March 2008 television commercials featuring artificial heart co-founder Dr. Robert Jarvik endorsing cholesterol drug Lipitor. The congressional committee...

  • Dr. Jarvik Doesn't Row. Wedekind, Jennifer // Multinational Monitor;Jul/Aug2008, Vol. 29 Issue 1, p60 

    The article discusses the background of the decision of the U.S. House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations to pull long-running Lipitor commercials featuring Dr. Robert Jarvik off the air in February 2008. It is noted that the commercials for...

  • Vytorin ad shame taints entire marketing industry. Thomaselli, Rich // Advertising Age;1/21/2008, Vol. 79 Issue 3, p1 

    This article examines how two pharmaceutical giants were able to create sales worth billions of dollars on the drug Vytorin when they had information that the drug did not reduce the build up of plaque in arteries as their advertising claimed. Schering-Plough and Merck had the results of a study...

  • Some New and Not-So-New Drugs That Are Heavily Promoted.  // HealthFacts;Feb2006, Vol. 31 Issue 2, p1 

    The article presents information on prescription drugs that are heavily promoted through direct-to-consumer advertisements. Components of the statin and cholesterol-lowering drug Vytorin are mentioned. Cautions regarding the use of the drug is mentioned. Names of some osteoporosis drugs are...

  • Despite small ad budget, Lipitor is No. 1 in category. Spain, William // Advertising Age;3/15/1999, Vol. 70 Issue 11, ps14 

    The article reports on the efforts of pharmaceutical companies to raise awareness of various cholesterol-lowering drugs through the use of direct-to-consumer (DTC) advertising in the U.S. One reason for the lack of advertisements for cholesterol-lowering drugs is insufficient background on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics